Larry Kraiss, MD is investigating a new treatment for patients with kidney disease who need dialysis, and is involved in a clinical trial of a drug that may reduce the rate of aneurysm growth.
As a Wylie Scholar, Dr. Kraiss studied how endothelial cells that line the blood vessels respond to changes in their environment including blood clots, inflammation, and changes in blood flow. He identified the triggers of abnormal cell growth due to vascular disease and laid the groundwork for new drug treatments and innovative therapies.
Dr. Kraiss runs a basic biology laboratory focused on endothelial cell biology and is Chief of the Division of Vascular Surgery at the University of Utah. He was director of the vascular surgery fellowship program at the University of Utah from 2003-2012.
He maintains a broad-based vascular surgery practice at the University of Utah. Dr. Kraiss has twice received teaching awards from the University of Utah general surgery residents (2000 and 2006). He is a regular reviewer for research proposals submitted to the NIH, NASA, and the Society for Vascular Surgery.
Dr. Kraiss is a member of the Vascular Cures Scientific Advisory Board.
“My two greatest successes were leveraging the Wylie Scholar award into over $2 million dollars of NIH research funding, and using the stature of the award to gain a voice at the table when vascular research priorities are being determined at a national level by the Society for Vascular Surgery and the National Heart, Lung, and Blood Institute.”